<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04806685</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00005457</org_study_id>
    <nct_id>NCT04806685</nct_id>
  </id_info>
  <brief_title>Diabetes Education and A1c Study</brief_title>
  <acronym>DEA1c</acronym>
  <official_title>Diabetes Education and A1c Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Michigan State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Blue Cross Blue Shield Foundation of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Michigan State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleep problems are associated with poor blood glucose control, but current diabetes&#xD;
      self-management programs do not include sleep education. This study will randomize&#xD;
      participants into two groups: one that receives sleep education and one that does not. The&#xD;
      researchers expect both groups to experience reductions in blood glucose. The researchers&#xD;
      hypothesize that individuals who receive sleep education as part of their diabetes&#xD;
      self-management training will experience greater improvements in blood glucose control, as&#xD;
      measured by hemoglobin A1c, compared to the control group.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">March 15, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemoglobin A1c</measure>
    <time_frame>12 weeks</time_frame>
    <description>Lab value</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>12 weeks</time_frame>
    <description>Calculated from height and weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep duration</measure>
    <time_frame>12 weeks</time_frame>
    <description>FitBit outcomes data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quality</measure>
    <time_frame>12 weeks</time_frame>
    <description>Pittsburgh Sleep Quality Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes self-care</measure>
    <time_frame>12 weeks</time_frame>
    <description>Diabetes Self-Management Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epworth Sleepiness Scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>Validated survey measuring excessive daytime sleepiness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insomnia Severity Index</measure>
    <time_frame>12 weeks</time_frame>
    <description>Validated survey measuring insomnia symptoms</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Sleep</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diet therapy plus sleep education</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Diet therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sleep education</intervention_name>
    <description>Medical nutrition therapy plus behavior-based sleep education intervention</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diet only</intervention_name>
    <description>No sleep education</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Individuals with a diagnosis of type 2 diabetes who are patients at the Michigan State&#xD;
             University (MSU) Endocrinology clinic,&#xD;
&#xD;
          -  a diagnosis of overweight or obesity (Body Mass Index greater than or equal to 25.0&#xD;
             kg/m2),&#xD;
&#xD;
          -  the most recent hemoglobin A1c value greater than or equal to 7.5%, and&#xD;
&#xD;
          -  the ability to attend online program sessions.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  significant psychiatric disorders,&#xD;
&#xD;
          -  advanced medical conditions that require alterations to the MNT for DM2, e.g.,&#xD;
             advanced chronic kidney disease, and&#xD;
&#xD;
          -  an inability to follow recommendations due to cognitive deficits.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Michigan State University</name>
      <address>
        <city>East Lansing</city>
        <state>Michigan</state>
        <zip>48824</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 15, 2021</study_first_submitted>
  <study_first_submitted_qc>March 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2021</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Michigan State University</investigator_affiliation>
    <investigator_full_name>Robin Tucker</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

